Drug
NBI 77860 clinical trials
Also written GSK561679.
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Other names
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 3
GlaxoSmithKline (5) · VA Office of Research and Development (1) · Emory University (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · Neurocrine Biosciences (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses NBI 77860 is read from its arms, and is right about nine times in ten.
Testing it · 9
- Analyzing Female Trauma Exposed Responses to a MedicationCompletedPhase 2VA Office of Research and DevelopmentNCT01814332Written as GSK561679
- A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive DisorderCompletedPhase 2GlaxoSmithKlineNCT00733980Written as GSK561679
- To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.CompletedPhase 1GlaxoSmithKlineNCT00426608Written as GSK561679
- A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety DisorderCompletedPhase 1GlaxoSmithKlineNCT00555139Written as GSK561679 tablet
- Evaluation of GSK561679 in Women With Post-Traumatic Stress DisorderCompletedPhase 2Emory UniversityNCT01018992Written as GSK561679
- CRF1 Antagonist GSK561679 in AlcoholismCompletedPhase 2National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT01187511Written as GSK561679
- Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal HyperplasiaWithdrawnPhase 1Neurocrine BiosciencesNCT02349503Written as NBI-77860
- A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679WithdrawnPhase 2GlaxoSmithKlineNCT00511563Written as GW876008 and GSK561679
- A Study to Examine the Absorption of GSK561679 in Healthy Male VolunteersCompletedPhase 1GlaxoSmithKlineNCT00539136Written as GSK561679 tablet or solution